XML 62 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Quarterly Financial Data (Tables)
12 Months Ended
Dec. 31, 2020
Quarterly Financial Data [Abstract]  
Schedule Of Quarterly Financial Data

2020

First

Second

Third

Fourth

Total

($ in millions, except per share amounts)

Quarter

Quarter

Quarter

Quarter

Year

Revenue

1,933 

1,801 

1,726 

1,695 

7,155 

Operating income(3)

272 

140 

270 

277 

959 

Net earnings (loss) attributable to Frontier

common shareholders (2)(3)

(186)

(181)

15 

(50)

(402)

Basic and diluted net earnings (loss) per share attributable

to Frontier common shareholders (1)(2)(3)

(1.78)

(1.73)

0.14 

(0.48)

(3.85)

(1)The quarterly net loss per share amounts are rounded to the nearest cent. Annual net loss per share may vary depending on the effect of such rounding.

(2)During 2020, Frontier recorded $409 million in reorganization items, net ($361 million net of tax) in connection with the Restructuring Plan.

(3)During 2020, we recorded aggregate losses on the disposal of our Northwest Operations of $162 million ($118 million after-tax). Refer to Note 7 for further details

2019

First

Second

Third

Fourth

Total

($ in millions, except per share amounts)

Quarter

Quarter

Quarter

Quarter

Year

Revenue (3)

2,101 

2,067 

1,997 

1,942 

8,107 

Operating income (loss) (2)(3)

339 

(5,459)

26 

221 

(4,873)

Net loss attributable to Frontier

common shareholders (2)(3)

(87)

(5,317)

(345)

(162)

(5,911)

Basic and diluted net loss per share attributable

to Frontier common shareholders (1)(2)(3)

(0.84)

(51.07)

(3.31)

(1.55)

(56.80)

(1)The quarterly net loss per share amounts are rounded to the nearest cent. Annual net loss per share may vary depending on the effect of such rounding.

(2)During 2019, we recorded aggregate goodwill impairment charges of $5,725 million ($5,201 million after-tax). Refer to Note 8 for further details.

(3)During 2019, we recorded aggregate losses on the disposal of our Northwest Operations of $446 million ($446 million after-tax). Refer to Note 7 for further details.